Whale Analyzer
Hillman Capital Management 13F Holdings and Portfolio Changes
Hillman Capital Management reported $138.2M in 13F securities for Q2 2026, with 54 positions. Values are as of the report date; option positions, when present, use underlying-security values. This is not complete fund assets or investment performance.
Open interactive portfolioLatest 13F portfolio changes
New or increased positions include DUPONT DE NEMOURS (DD), ADOBE (ADBE), ISHARES TR (EFA), and NIKE (NKE). Reduced or exited positions include CVS HEALTH (CVS), DUPONT DE NEMOURS (DD), BIOGEN (BIIB), and WARNER BROS DISCOVERY (WBD). These are comparisons between reported positions, not a record of execution dates, prices or cash traded.
Latest filing metadata: quarter Q2 2026; report date 2026-06-30; filing date 2026-08-14; disclosure source SEC 13F.
Reported holdings and concentration
Hillman Capital Management's Q2 2026 13F report contains 54 positions valued at $138.2M. The largest reported holdings include CVS HEALTH, BIOGEN, DUPONT DE NEMOURS, WARNER BROS DISCOVERY, and BAXTER INTL.
The three largest positions in the holdings table account for approximately 11.6% of reported 13F value. The largest reported sector exposure is Other at 25.3% of the disclosed portfolio.
The filing metadata lists report date 2026-06-30, filing date 2026-08-14, SEC accession 0001398344-26-014467. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.
Hillman Capital Management portfolio analytics
the top five positions account for 18.9% of disclosed value; the largest sector exposure is Health Care at 20.2%.
Top reported holdings
| Holding | Reported value | Weight | Quarter change |
|---|---|---|---|
| CVS whale holders CVS HEALTH CORP | $5.7M | 4.2% | Reduced |
| BIIB whale holders BIOGEN INC | $5.2M | 3.8% | Reduced |
| DD whale holders DUPONT DE NEMOURS INC | $5.1M | 3.7% | New |
| WBD whale holders WARNER BROS DISCOVERY INC | $5.1M | 3.7% | Reduced |
| BAX whale holders BAXTER INTL INC | $5.0M | 3.6% | Reduced |
| IFF whale holders INTERNATIONAL FLAVORS&FRAGRA | $5.0M | 3.6% | Reduced |
| GSK whale holders GSK PLC | $4.8M | 3.5% | Reduced |
| KMX whale holders CARMAX INC | $4.8M | 3.5% | Reduced |
| BA whale holders BOEING CO | $4.7M | 3.4% | Reduced |
| ZBH whale holders ZIMMER BIOMET HOLDINGS INC | $4.6M | 3.4% | Reduced |
New and increased positions
Largest reported position values among additions; not amounts spent buying.
- DD whale holders — DUPONT DE NEMOURS INC ($5.1M)
- ADBE whale holders — ADOBE INC ($3.5M)
- EFA whale holders — ISHARES TR ($3.3M)
- NKE whale holders — NIKE INC ($3.2M)
- VEEV whale holders — VEEVA SYS INC ($2.5M)
- CMCSA whale holders — COMCAST CORP NEW ($2.5M)
Reduced and exited positions
Sorted by reported position value; exits use the prior report. These are not sale proceeds.
- CVS whale holders — CVS HEALTH CORP ($5.7M)
- DD whale holders — DUPONT DE NEMOURS INC ($5.4M)
- BIIB whale holders — BIOGEN INC ($5.2M)
- WBD whale holders — WARNER BROS DISCOVERY INC ($5.1M)
- BAX whale holders — BAXTER INTL INC ($5.0M)
- IFF whale holders — INTERNATIONAL FLAVORS&FRAGRA ($5.0M)
Allocation
- Other: 25.3%
- Health Care: 20.2%
- Information Technology: 15.0%
- Communication Services: 9.2%
- Materials: 7.6%
- Consumer Staples: 6.5%
- Industrials: 5.4%
- Consumer Discretionary: 5.2%
Data notes
Report date: 2026-06-30
Disclosure source: SEC 13F
Read the original SEC filing (0001398344-26-014467)
SEC 13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.
Related investor portfolios
Profiles with the same disclosure type, ordered by overlap among their top 20 reported holdings.
- Fairholme Capital Management 13F holdings and portfolio changes — Fairholme Capital Management
- Dodge & Cox 13F holdings and portfolio changes — Dodge & Cox
- Fairfax Financial Holdings 13F holdings and portfolio changes — Fairfax Financial Holdings
- First Pacific Advisors 13F holdings and portfolio changes — First Pacific Advisors
- Vulcan Value Partners 13F holdings and portfolio changes — Vulcan Value Partners
- Kahn Brothers Group 13F holdings and portfolio changes — Kahn Brothers Group
- Lindsell Train 13F holdings and portfolio changes — Lindsell Train
- Patient Capital Management 13F holdings and portfolio changes — Patient Capital Management
Learn more in Whale Analyzer Academy
Learn more in Whale Analyzer Academy:
Questions about this 13F filing
What does Hillman Capital Management report for Q2 2026?
The filing reports 54 positions and $138.2M in 13F securities. The holdings table shows reported values and weights; option values follow the filing's reporting conventions.
What changed between filings?
New or increased positions include DUPONT DE NEMOURS (DD), ADOBE (ADBE), ISHARES TR (EFA), and NIKE (NKE). Reduced or exited positions include CVS HEALTH (CVS), DUPONT DE NEMOURS (DD), BIOGEN (BIIB), and WARNER BROS DISCOVERY (WBD).
Do these amounts show how much was bought or sold?
No. The change lists are ranked by reported position value. Exited positions use their value in the prior report. These amounts are not execution prices, cash invested or sale proceeds.
Is this the current portfolio?
No. Form 13F is a quarter-end snapshot, generally filed within 45 days of quarter end. It excludes short positions and does not cover every asset. Compare the report date and filing date before using the data.